Description
1. Product Overview
D-Mannose is a naturally occurring monosaccharide, structurally related to glucose, produced via certified enzymatic hydrolysis and crystallization processes for high-purity industrial applications. Its primary industrial use is as a precision intermediate in nutraceutical, pharmaceutical, and specialty food formulations targeting urinary tract health, along with applications in glycoprotein synthesis and bioprocessing. The key value proposition is a verified ≥99% purity, endotoxin-controlled profile, and non-GMO source material, enabling predictable performance in sensitive biological environments. Strategically, this product is critical for global manufacturers seeking to scale urinary health solutions and biopharmaceutical excipients amid rising demand for antibiotic-alternative preventive care.
2. Key Specifications & Technical Characteristics
-
Chemical Composition: D-Mannose (C₆H₁₂O₆), CAS No. 3458-28-4, derived from non-GMO corn or birch via enzymatic conversion
-
Purity Grade: ≥99.0% (HPLC), with pharmaceutical-grade (EP/USP) and food-grade options
-
Physical Characteristics:
-
Form: Fine, free-flowing crystalline powder
-
Color: White to off-white
-
Particle size: D90 ≤ 150 µm (standard); customized milling available (D90 50–200 µm)
-
Bulk density: 0.55–0.75 g/cm³ (untapped); 0.75–0.95 g/cm³ (tapped)
-
Moisture content: ≤1.0% (Karl Fischer)
-
-
Impurity Profile: Heavy metals ≤10 ppm, lead ≤0.5 ppm, arsenic ≤1 ppm, residual solvents meet ICH Q3C
-
Packaging Options: 25 kg multi-layer kraft/PE bags; 500 kg FIBCs; custom sterile pharmaceutical drums (20 kg)
-
Shelf Life: 36 months from manufacture date when stored in original sealed packaging under cool (15–25°C), dry (≤50% RH) conditions
3. Core Industrial Applications
-
Nutraceutical Manufacturing: Primary use in tablet, capsule, powder stick, and gummy formulations for urinary tract infection (UTI) prevention. D-Mannose outperforms cranberry extracts due to clinically validated mechanism of binding E. coli FimH adhesins, with no caloric interference or sugar metabolism issues in diabetic populations.
-
Pharmaceutical Intermediates: Used as a starting material for synthesis of mannose-6-phosphate (M6P) in enzyme replacement therapies (ERT) for lysosomal storage disorders. Its high purity reduces downstream purification steps by ≥30%, lowering cost of goods.
-
Bioprocessing & Cell Culture: Serves as a controlled osmolyte and glycosylation modulator in mammalian cell culture media (CHO cells). Superior to D-glucose for maintaining glycoprotein yield consistency, with batch-to-batch variability <2% RSD.
-
Specialty Food & Infant Formula: Added as a prebiotic-like sugar and excipient in medical foods. Its low glycemic index (GI = 0) and resistance to fermentation provide functional advantage over fructose or maltodextrin in enteral nutrition products.
4. Competitive Advantages
-
Quality Consistency: ISO 9001:2015 and FSSC 22000 certified facilities. Each lot tested for purity, residual solvents, heavy metals, microbial limits (TAMC ≤100 cfu/g), and endotoxins (<10 EU/g for pharma grade). CoA provided with every shipment.
-
Supply Reliability: Dual sourcing from North America and Europe with 6-month rolling forecast commitment. Dedicated buffer stock of 60+ MT maintained in climate-controlled warehouses on three continents.
-
Logistics Capability: Expedited 5-day dispatch for standard grades; 15-day lead time for custom particle size/pharma-grade documentation. Real-time trackable shipping via partnered freight forwarders (Kuehne+Nagel, DSV).
-
Price Competitiveness: Volume pricing 15–25% below European spot averages through vertically integrated enzymatic production, eliminating costly botanical extraction steps.
-
Sustainability: 98% solvent recovery rate in crystallization; birch-derived variant uses renewable forestry with FSC-certified sourcing. Non-GMO project verified and Kosher/Halal certified available.
-
Technical Support: Access to application lab for dissolution studies, compatibility testing, and regulatory dossier support (DMF Type II available upon NDA).
5. Commercial & Supply Information
-
Minimum Order Quantity (MOQ): 500 kg for standard grade (25 kg bags); 1,000 kg for pharmaceutical/USP grade
-
BULK 20MT Loading Capacity: 20 metric tons net weight fits as:
-
20′ dry container: 800 × 25 kg bags (20 MT) with palletized configuration (20 Euro pallets)
-
20′ container max payload: 21.5 MT; our standard loading is 20 MT to allow sampling access
-
-
Incoterms Offered: EXW (warehouse – Rotterdam / Chicago / Shanghai), FOB, CIF, DDP upon qualification
-
Lead Time for 20MT Bulk Order: 12–18 working days after advance payment or LC confirmation
-
Payment Terms: Letter of Credit (L/C at sight), T/T advance (30/70), or net 30 days for established credit-approved buyers












Reviews
There are no reviews yet.